{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:04:22Z","timestamp":1790636662424,"version":"4.1.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Messenger RNA (mRNA) vaccines have revolutionized vaccinology with their rapid development cycles and adaptability, yet their broad application is constrained by unresolved challenges in balancing mRNA structural stability and translational efficiency. Here, we introduce a groundbreaking multi-seed searching algorithm for mRNA codon optimization, an innovative framework that synergistically co-optimizes minimum free energy and codon adaptation index through adaptive integration of simulated annealing and genetic algorithms. This novel approach enhances global search capability to escape local optima, a critical limitation of existing tools. Evaluations across long therapeutic mRNA sequences and short peptides (neoantigens from bladder cancer and melanoma) reveal our algorithm outperforms state-of-the-art LinearDesign, delivering superior balanced improvements in both stability and translational efficiency validating its unique ability to navigate the inherent trade-offs between these two key metrics. Built on this algorithm, the Optiseed platform introduces transformative features including customizable scoring functions, flexible parameters for tailored optimization, and support for integrating untranslated regions (UTRs), poly(A) tails, and other elements to enable end-to-end vaccine construct design. This innovation addresses the rigidity of conventional tools, empowering precise, context-specific optimization. Optiseed represents a robust, scalable solution for mRNA vaccine codon optimization. Its superior performance across diverse sequences underscores its potential to accelerate mRNA-based therapeutic development, particularly in personalized cancer immunotherapy, while offering a framework adaptable for other applications such as infectious disease vaccine design.<\/jats:p>","DOI":"10.1093\/bib\/bbag047","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T12:59:37Z","timestamp":1769086777000},"source":"Crossref","is-referenced-by-count":1,"title":["Multi-seed searching algorithm for integrated codon optimization of mRNA stability and translational efficiency in vaccine design"],"prefix":"10.1093","volume":"27","author":[{"given":"Yuhan","family":"Bo","sequence":"first","affiliation":[{"name":"Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education, Beijing Advanced Innovation Center for Biomedical Engineering, School of Engineering Medicine, Beihang University , No. 37 Xueyuan Road, Haidian District, 100191 Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxin","family":"Liu","sequence":"additional","affiliation":[{"name":"Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education, Beijing Advanced Innovation Center for Biomedical Engineering, School of Engineering Medicine, Beihang University , No. 37 Xueyuan Road, Haidian District, 100191 Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyu","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Computer Science and Technology, Beihang University , No. 37 Xueyuan Road, Haidian District, 100191 Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Beijing Tiantan Hospital, Capital Medical University , No. 119 South Forth Ring West Road, Fentai District, Beijing 100070 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libin","family":"Deng","sequence":"additional","affiliation":[{"name":"Nanchang People's Hospital, Data Governance Center , Nanchang ,","place":["China"]},{"name":"School of Public Health, Jiangxi Medical College, Jiangxi Provincial Key Laboratory of Disease Prevention and Public Health, Nanchang University , Nanchang ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dake","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education, Beijing Advanced Innovation Center for Biomedical Engineering, School of Engineering Medicine, Beihang University , No. 37 Xueyuan Road, Haidian District, 100191 Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8549-3286","authenticated-orcid":false,"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education, Beijing Advanced Innovation Center for Biomedical Engineering, School of Engineering Medicine, Beihang University , No. 37 Xueyuan Road, Haidian District, 100191 Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"2026020912385818800_ref1","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"2026020912385818800_ref2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"2026020912385818800_ref3","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1093\/nar\/gkr695","article-title":"Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA","volume":"39","author":"Karik\u00f3","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"2026020912385818800_ref4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40779-022-00416-w","article-title":"Personalized pancreatic cancer therapy: from the perspective of mRNA vaccine","volume":"9","author":"Huang","year":"2022","journal-title":"Mil Med Res"},{"key":"2026020912385818800_ref5","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1158\/2159-8290.Cd-nb2023-0038","article-title":"Personalized mRNA vaccine immunogenic against PDAC","volume":"13","year":"2023","journal-title":"Cancer Discov"},{"key":"2026020912385818800_ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186582","article-title":"mRNA vaccine era-mechanisms, drug platform and clinical prospection","volume":"21","author":"Xu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026020912385818800_ref7","doi-asserted-by":"publisher","first-page":"eadn9961","DOI":"10.1126\/sciadv.adn9961","article-title":"Lipopolyplex-formulated mRNA cancer vaccine elicits strong neoantigen-specific T cell responses and antitumor activity","volume":"10","author":"Fan","year":"2024","journal-title":"Sci Adv"},{"key":"2026020912385818800_ref8","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2256422","article-title":"An mRNA-based broad-spectrum vaccine candidate confers cross-protection against heterosubtypic influenza a viruses","volume":"12","author":"Xiong","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"2026020912385818800_ref9","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.xphs.2020.12.006","article-title":"Addressing the cold reality of mRNA vaccine stability","volume":"110","author":"Crommelin","year":"2021","journal-title":"J Pharm Sci"},{"key":"2026020912385818800_ref10","doi-asserted-by":"publisher","first-page":"108015","DOI":"10.1016\/j.jbc.2024.108015","article-title":"mRNA vaccine sequence and structure design and optimization: advances and challenges","volume":"301","author":"Jin","year":"2025","journal-title":"J Biol Chem"},{"key":"2026020912385818800_ref11","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41586-023-06127-z","article-title":"Algorithm for optimized mRNA design improves stability and immunogenicity","volume":"621","author":"Zhang","year":"2023","journal-title":"Nature"},{"key":"2026020912385818800_ref12","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1093\/nar\/15.3.1281","article-title":"The codon adaptation index--a measure of directional synonymous codon usage bias, and its potential applications","volume":"15","author":"Sharp","year":"1987","journal-title":"Nucleic Acids Res"},{"key":"2026020912385818800_ref13","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.49708","article-title":"GC content shapes mRNA storage and decay in human cells","volume":"8","author":"Courel","year":"2019","journal-title":"Elife"},{"key":"2026020912385818800_ref14","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab911","article-title":"Theoretical basis for stabilizing messenger RNA through secondary structure design","volume":"49","author":"Wayment-Steele","journal-title":"Nucleic Acids Res"},{"key":"2026020912385818800_ref15","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/s41467-022-28776-w","article-title":"Combinatorial optimization of mRNA structure, stability, and translation for RNA-based therapeutics","volume":"13","author":"Leppek","year":"2022","journal-title":"Nat Commun"},{"key":"2026020912385818800_ref16","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.cell.2015.02.029","article-title":"Codon optimality is a major determinant of mRNA stability","volume":"160","author":"Presnyak","year":"2015","journal-title":"Cell"},{"key":"2026020912385818800_ref17","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1016\/j.jmb.2019.04.021","article-title":"Codon and codon-pair usage tables (CoCoPUTs): facilitating genetic variation analyses and recombinant Gene Design","volume":"431","author":"Alexaki","year":"2019","journal-title":"J Mol Biol"},{"key":"2026020912385818800_ref18","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1158\/0008-5472.Can-11-2957","article-title":"Preclinical evaluation of TriMix and antigen mRNA-based antitumor therapy","volume":"72","author":"Van Lint","year":"2012","journal-title":"Cancer Res"},{"key":"2026020912385818800_ref19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12943-021-01342-6","article-title":"Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development","volume":"20","author":"Huang","year":"2021","journal-title":"Mol Cancer"},{"key":"2026020912385818800_ref20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41541-024-00813-3","article-title":"A therapeutic hepatitis B mRNA vaccine with strong immunogenicity and persistent virological suppression","volume":"9","author":"Zhao","year":"2024","journal-title":"npj Vaccines"},{"key":"2026020912385818800_ref21","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat9143","article-title":"Durable anticancer immunity from intratumoral administration of IL-23, IL-36\u03b3, and OX40L mRNAs","volume":"11","author":"Hewitt","year":"2019","journal-title":"Sci Transl Med"},{"key":"2026020912385818800_ref22","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1007\/s00432-022-04325-2","article-title":"Discovery and characterization of tumor antigens in hepatocellular carcinoma for mRNA vaccine development","volume":"149","author":"Fu","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"2026020912385818800_ref23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41586-020-2537-9","article-title":"An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma","volume":"585","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"2026020912385818800_ref24","doi-asserted-by":"publisher","first-page":"975408","DOI":"10.3389\/fonc.2022.975408","article-title":"An OX40L mRNA vaccine inhibits the growth of hepatocellular carcinoma","volume":"12","author":"Deng","year":"2022","journal-title":"Front Oncol"},{"key":"2026020912385818800_ref25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"key":"2026020912385818800_ref26","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/s0140-6736(23)02268-7","article-title":"Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study","volume":"403","author":"Weber","year":"2024","journal-title":"Lancet"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/27\/1\/bbag047\/66821901\/bbag047.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/27\/1\/bbag047\/66821901\/bbag047.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T17:39:07Z","timestamp":1770658747000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbag047\/8469532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,7]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbag047","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1]]},"article-number":"bbag047"}}